Our platform enables pharmaceutical companies and university medical centers (UMC) to perform advanced monitoring of their patients’ health during new clinical trial projects
For New Treatment
Our system examines and collects user bio-signals according to clinical trial protocols, while also performing analyses of their changes and deviations. Changes to bio-signals may reflect how particular medicines affect users’ health and patients’ eligibility for specific medical products. As such, our system can provide early warnings based on AI models, as well as deliver automated, data-based reports for each individual patient.
For New Pharmaceuticals Researchers
All new medicines must be thoroughly checked, monitored, and maintained, so as to provide the best results and avoid adverse effects on patients. Our system performs automated bio-signal collection, as well as logs personal information, complaints, and other crucial data to provide a more comprehensive and accurate look at research results and reasoned conclusions. All new research projects are conducted with compliance to individual research requirements.
- Medical researchers can provide their patients and volunteers with continuous health monitoring and reports, based on regular and ample amounts of data.
- If the dHealth system detects negative health changes to patients or volunteers, it automatically reports all findings and data to medical researchers and their patients.
- Medical researchers are equipped with comprehensive information about each patient’s health behavior during new medical research or the use of new medical products.
- dHealth system automates the process of individual data collection, while optimizing the turnaround time of research analyses.